The latest MDS UK Patient and Family Forum took place in Birmingham on the 4th of February. It was an invaluable opportunity for those affected by MDS to hear about […]

In this presentation from the 2016 “European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes”, Dr. Fabio Efficace discusses the importance of quality of life as a treatment goal in myelodysplastic […]

Researchers designed an antibody that recognises and destroys CD99-covered leukemia cells while sparing normal blood stem cells

Dr. Garcia Manero, from The University of Texas MD Anderson Cancer Center, highlights some promising clinical data presented at the 58th Annual Meeting of the American Society of Haematology (ASH)

Evidence tells us that when patients are actively involved in their own care, treatment and support can improve outcomes and experience for patients. Everyone involved in care should advocate for the […]

As of the 20th of October, the European Medicines Agency (EMA) gives open access to clinical reports for new medicines authorised in the European Union. For every new medicine, citizens, […]

Leukaemia Care is asking patients to fill in a new questionnaire about their care and treatment for blood cancer. Its purpose is to provide information, which will help the NHS […]

Fresher is not better It’s been long thought that when blood transfusions are needed, it may be best to use the freshest blood, but McMaster University researchers have led a […]